ٍEnglish News
Cellectis Gets FDA Approval for Third CAR-T Cell Trial
The FDA approved an investigational new drug application from Cellectis for a Phase 1 clinical trial of UCART22, its third gene-edited CAR-T cell candidate.
 ١٠:٥ - 1397/03/29 - نظرات : ٠متن کامل >>
CRISPR growing in cancer care, but will insurance companies pick up the cost?
Christiana Care has been talking with the U.S. Food & Drug Administration about developing a gene editing tool called CRISPR to assist in lung cancer treatments. One question they?ll face in the future is if insurance companies will pick up the cost.
 ١٢:٢٢ - 1397/03/28 - نظرات : ٠متن کامل >>
Million-dollar Kavli prize recognizes scientist scooped on CRISPR
Award? goes to biochemists Virginijus Siksnys, whose lab independently developed the gene-editing tool, Emmanuelle Charpentier and Jennifer Doudna.
 ١٢:١ - 1397/03/23 - نظرات : ٠متن کامل >>
The 3rd National Festival and International Congress on Stem Cells and Regenerative Medicine
For more information, you can visit the festival?s website at: stemcellfestival.com
 ٠٨:٤٦ - 1397/03/02 - نظرات : ٠متن کامل >>
Even Old Brains Can Make New Neurons, Study Finds
In research published today in the journal Cell Stem Cell, scientists at Columbia University Vagelos College of Physicians and Surgeons present the most definitive evidence to date that the human brain makes new neurons throughout life.
 ٠٨:٤٥ - 1397/03/02 - نظرات : ٠متن کامل >>
New Company, MAGiQ, Aims to Develop Stem Cell Therapies for ALS and Like Diseases
FDA Approves CAR-T Cell Therapy for Diffuse Large B-Cell Lymphoma
Scientists improve DNA transfer in gene therapy
$11.6 Million NIH Grant Supports Temple Researchers? Exploration of New Cell-Free Stem Cell-Based Possibilities in Heart Repair
Cancer ?vaccine? eliminates tumors in mice
Visitors` Statistics
 بازدید این صفحه : 1057
 بازدید امروز : 30
 کل بازدید : 31326
 بازدیدکنندگان آنلاين : 3
 زمان بازدید : 0.31